Abstract: For patients with gastric and colorectal cancers, peritoneal carcinomatosis is a landmark event of advanced clinical stage. The effectiveness of traditional treatment modality, including systematic chemotherapy and/or palliative surgery, is disappointing due to the poor survival rate and quality of life. Hyperthermic intraperitoneal chemotherapy plus cytoreductive surgery, which has emerged as a new treatment modality, has been demonstrated to improve both the survival and the quality of life in selected patients with peritoneal carcinomatosis. This treatment strategy has become a well received standard therapy for colorectal cancer patients with peritoneal carcinomatosis. However, such multidisciplinary approach has not obtained right recognition and application in Mainland China. This review analyzed the current status of the diagnosis and treatment of peritoneal carcinomatosis in China, and presented practical suggestions to promote the standard treatment of peritoneal carcinomatosis in China.